Should Diagnostics & Research Stock Danaher Corporation (DHR) Be in Your Portfolio Wednesday?

Danaher Corporation (DHR) is near the top in its industry group according to InvestorsObserver. DHR gets an overall rating of 62. That means it scores higher than 62 percent of stocks. Danaher Corporation gets a 91 rank in the Diagnostics & Research industry. Diagnostics & Research is number 73 out of 148 industries.

DHR has an Overall Score of 62. Find out what this means to you and get the rest of the rankings on DHR!

See Full DHR Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes

InvestorsObserver

’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Danaher Corporation Stock Today?

Danaher Corporation (DHR) stock has risen 0.79% while the S&P 500 is lower by -0.95% as of 2:54 PM on Wednesday, Nov 10. DHR has risen $2.48 from the previous closing price of $299.19 on volume of 1,338,877 shares. Over the past year the S&P 500 has gained 30.89% while DHR has risen 33.50%. DHR earned $7.87 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 38.32. Click Here to get the full Stock Report for Danaher Corporation stock.